The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

Vertex Pharmaceuticals (VRTX) and Neurocrine Biosciences (NBIX) shares are moving sharply after their respective earnings ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company’s Chief Financial ...

"As we continue to advance our pipeline of innovative inhaled therapeutics for pulmonary and systemic diseases with high ...

BOULDER, Colo., May 06, 2025 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical ...

NRx Pharma files patent application for NRX-100, its proprietary, preservative free formulation of IV ketamine: Wilmington, Delaware Tuesday, May 6, 2025, 17:00 Hrs [IST] NRx Phar ...

The MOU aims to collaborate on enhancing public health services, awareness programs, and advancing disease management through ...

ANN ARBOR, Mich. (AP) — ANN ARBOR, Mich. (AP) — Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $40.5 million in its first quarter. On a per-share basis, the Ann Arbor, Michigan-based ...

Results from studies at Virginia Commonwealth University (VCU) show that an Aramchol and Bayer's Regorafenib drug combination significantly reduced hepatic tumor ...

Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the ...

AI and automation are revolutionizing biopharmaceutical manufacturing by enhancing efficiency, improving quality control and ...

BHVN's Troriluzole awaits pivotal FDA approval in 2025, backed by $600M funding. Explore its diverse pipeline and promising ...